ResMed Inc (RMD) - Total Liabilities
Based on the latest financial reports, ResMed Inc (RMD) has total liabilities worth $2.29 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ResMed Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
ResMed Inc - Total Liabilities Trend (1993–2025)
This chart illustrates how ResMed Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see RMD asset base.
ResMed Inc Competitors by Total Liabilities
The table below lists competitors of ResMed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ryanair Holdings plc
IR:RYA
|
Ireland | €7.42 Billion |
|
SEVEN+I HLDGS UNSP.ADR1/2
F:S6MA
|
Germany | €7.63 Trillion |
|
Bank Rakyat Indonesia Persero
JK:BBRI
|
Indonesia | Rp1784.30 Trillion |
|
Telefonaktiebolaget LM Ericsson (publ)
F:ERCA
|
Germany | €183.13 Billion |
|
RYANAIR HLDGS ADR NEW/5
F:RY4D
|
Germany | €7.26 Billion |
|
Willis Towers Watson PLC
NASDAQ:WTW
|
USA | $21.48 Billion |
|
SHINHAN FINL ADR/1 SW5000
F:KSF1
|
Germany | €725.64 Trillion |
|
Fortis Inc
TO:FTS
|
Canada | CA$51.30 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down ResMed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See RMD net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ResMed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ResMed Inc (1993–2025)
The table below shows the annual total liabilities of ResMed Inc from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $2.21 Billion | +9.87% |
| 2024-06-30 | $2.01 Billion | -23.40% |
| 2023-06-30 | $2.62 Billion | +51.10% |
| 2022-06-30 | $1.74 Billion | -5.83% |
| 2021-06-30 | $1.84 Billion | -11.86% |
| 2020-06-30 | $2.09 Billion | +2.70% |
| 2019-06-30 | $2.04 Billion | +102.55% |
| 2018-06-30 | $1.00 Billion | -33.37% |
| 2017-06-30 | $1.51 Billion | -3.57% |
| 2016-06-30 | $1.56 Billion | +162.01% |
| 2015-06-30 | $596.95 Million | -0.96% |
| 2014-06-30 | $602.71 Million | +0.42% |
| 2013-06-30 | $600.21 Million | +13.19% |
| 2012-06-30 | $530.24 Million | +56.79% |
| 2011-06-30 | $338.19 Million | -0.20% |
| 2010-06-30 | $338.86 Million | -13.73% |
| 2009-06-30 | $392.78 Million | +21.14% |
| 2008-06-30 | $324.23 Million | +1.06% |
| 2007-06-30 | $320.82 Million | +19.23% |
| 2006-06-30 | $269.07 Million | -10.33% |
| 2005-06-30 | $300.08 Million | +59.91% |
| 2004-06-30 | $187.65 Million | +8.37% |
| 2003-06-30 | $173.16 Million | -5.51% |
| 2002-06-30 | $183.26 Million | -2.38% |
| 2001-06-30 | $187.72 Million | +768.21% |
| 2000-06-30 | $21.62 Million | +18.22% |
| 1999-06-30 | $18.29 Million | +32.53% |
| 1998-06-30 | $13.80 Million | +33.98% |
| 1997-06-30 | $10.30 Million | +24.10% |
| 1996-06-30 | $8.30 Million | +29.69% |
| 1995-06-30 | $6.40 Million | +60.00% |
| 1994-06-30 | $4.00 Million | +73.91% |
| 1993-06-30 | $2.30 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more